Insulin resistance in perimenopause: the earliest warning sign most doctors miss

By the time fasting glucose is elevated, insulin resistance has usually been developing for five to ten years. In perimenopausal women, that silent decade often coincides exactly with the hormonal transition — which is why so many women arrive at their doctor with new weight gain, sugar cravings, and afternoon fatigue only to be told "your glucose is normal, everything looks fine."

What insulin resistance actually is

Insulin is the hormone that shuttles glucose from your bloodstream into your cells. When cells become less responsive to insulin — a state called insulin resistance — the pancreas compensates by pumping out more of it. Fasting glucose stays normal for years while fasting insulin climbs. Eventually the pancreas cannot keep up, and glucose begins to rise. That final step is pre-diabetes; everything before it is invisible on a standard glucose test.

Why perimenopause accelerates it

Estradiol directly improves insulin signaling in muscle and liver. As estradiol becomes erratic in perimenopause, so does insulin sensitivity — often week to week. Poor sleep (also driven by hormonal shifts) worsens insulin resistance the next day. Cortisol rises. Visceral fat begins to accumulate around the midsection. Each of these amplifies the others.

Symptoms most women dismiss

• New sugar or carb cravings, especially in the afternoon
• Energy crashes 60–90 minutes after eating
• Waking at 3 a.m. unable to fall back asleep
• Thickening around the waist despite unchanged diet
• Skin tags, especially on the neck or under the arms
• Darkened skin folds (acanthosis nigricans) at the neck or armpits
• Increasingly irregular periods

The tests that catch it early

Some clinicians use fasting insulin to estimate insulin resistance (HOMA-IR), but there's no standard cutoff and it isn't a routine screening test. HbA1c and fasting glucose are the standard tests for prediabetes, so ask your clinician which tests make sense for you. HbA1c is helpful but lags. A continuous glucose monitor worn for two weeks can also reveal post-meal glucose spikes and overnight patterns that fasting labs miss.

What can improve it

The most powerful non-pharmacologic intervention is resistance training — building muscle creates new sites for insulin-mediated glucose disposal. Protein-forward meals stabilize post-prandial glucose. Prioritizing 7+ hours of sleep matters; in controlled studies, restricting sleep impaired glucose tolerance. Where symptoms are severe or metabolic risk is elevated, hormone therapy started in the perimenopausal window improves insulin sensitivity meaningfully. For women meeting clinical criteria, GLP-1 therapy may be an option.

The bottom line

Insulin resistance is the earliest, most actionable warning of metabolic menopause. Catching it in perimenopause — rather than waiting for a pre-diabetes diagnosis at 55 — is one of the highest-leverage moves a woman can make for her long-term health.

Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team, led by Kevin Wolfe, CMO
NPI 1609792902 · Last reviewed: July 25, 2026